Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Harm Sleeboom"'
Autor:
Roger von Moos, Jean-Jacques Body, Oliver Guenther, Evangelos Terpos, Yves Pascal Acklin, Jindrich Finek, João Pereira, Nikos Maniadakis, Guy Hechmati, Susan Talbot, Harm Sleeboom
Publikováno v:
Journal of Bone Oncology, Vol 10, Iss C, Pp 49-56 (2018)
Background: Bone metastases and lytic lesions due to multiple myeloma are common in advanced cancer and can lead to debilitating complications (skeletal-related events [SREs]), including requirement for radiation to bone. Despite the high frequency o
Externí odkaz:
https://doaj.org/article/eb7c23d709e04c5093ed19529f04fb48
Autor:
Evangelos Terpos, Harm Sleeboom, João Pereira, Susan Talbot, Nikos Maniadakis, Yves Pascal Acklin, Guy Hechmati, Jindrich Finek, Oliver Guenther, Jean-Jacques Body, Roger von Moos
Publikováno v:
Journal of Bone Oncology, Vol 10, Iss C, Pp 49-56 (2018)
Journal of Bone Oncology
Journal of Bone Oncology, 10
Journal of Bone Oncology
Journal of Bone Oncology, 10
Background: Bone metastases and lytic lesions due to multiple myeloma are common in advanced cancer and can lead to debilitating complications (skeletal-related events [SREs]), including requirement for radiation to bone. Despite the high frequency o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aece54ef0bb5f97965a732c23b62f38f
http://www.sciencedirect.com/science/article/pii/S2212137417301045
http://www.sciencedirect.com/science/article/pii/S2212137417301045
Autor:
Jean-Jacques Body, Evangelos Terpos, Harm Sleeboom, João Pereira, Yves Pascal Acklin, Nikos Maniadakis, Guy Hechmati, Roger von Moos, Susan Talbot, Jindrich Finek, O. Gunther
Publikováno v:
Journal of Bone Oncology
Journal of Bone Oncology, 5 (4
Journal of Bone Oncology, 5 (4
Background Skeletal-related events (SREs; pathologic fracture [PF], spinal cord compression and radiation or surgery to bone) are common complications of bone metastases or bone lesions and can impose a considerable burden on patients and healthcare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b115fcfd4e70e302e23bc399fad88bfc
https://doi.org/10.1016/j.jbo.2016.07.003
https://doi.org/10.1016/j.jbo.2016.07.003
Autor:
N. Maniadakis, Jean-Jacques Body, Evangelos Terpos, Harm Sleeboom, João Pereira, Yves Pascal Acklin, R von Moos, Guy Hechmati, Jindrich Finek, O. Gunther
Publikováno v:
Journal of medical economics. 19(6)
Objective Patients with bone metastases or lesions secondary to solid tumors or multiple myeloma often experience bone complications (skeletal-related events [SREs]-radiation to bone, pathologic fracture, surgery to bone, and spinal cord compression)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::818b436cd684b3e8e28e9580fbbec324
https://pubmed.ncbi.nlm.nih.gov/26849381
https://pubmed.ncbi.nlm.nih.gov/26849381
Autor:
Henning T. Mouridsen, J. Arnold Verbeek, Yan Sun, Eeva Salminen, H. A. Chaudri-Ross, Fritz Jänicke, Dominique Becquart, Justus Apffelstaedt, Beatrix Staffler, Anna Pluzanska, Magdolna Dank, Robert S. Smith, Ramon Perez-Carrion, Margaret Dugan, Mikhail Gershanovich, Alain Monnier, Mercedes Lassus, Poonamalle P. Bapsy, Harm Sleeboom, Corrado Boni, Raymond Snyder
Publikováno v:
Journal of Clinical Oncology. 19:2596-2606
PURPOSE: To compare the efficacy and tolerability of tamoxifen with that of letrozole, an oral aromatase inhibitor, with tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer. PATIENTS AND METHODS: Nine hundred seven pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1db3f2ace9ebe08ee91f8d4c3a0473
https://doi.org/10.1200/jco.2001.19.10.2596
https://doi.org/10.1200/jco.2001.19.10.2596
Autor:
Jo Hermans, G. Blijham, Louk V.A.M. Beex, A.T.M. van Holten-Verzantvoort, Socrates E. Papapoulos, F.J. Cleton, B.C.F. van Eck-Smit, Harm Sleeboom
Publikováno v:
European Journal of Cancer, 32, 450-454
European Journal of Cancer, 32, 3, pp. 450-454
European Journal of Cancer, 32, 3, pp. 450-454
The effect of pamidronate treatment on the first development of bone metastases was investigated in 124 patients with breast cancer, with either locally advanced disease (n = 33) or extraskeletal metastases (n = 91), but no bone metastases in a rando
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b9b9d4e19331aabb6e8fc56f933912
https://hdl.handle.net/2066/23729
https://hdl.handle.net/2066/23729
Autor:
R. von Moos, Harm Sleeboom, Vera Hirsh, G.V. Scagliotti, David H. Henry, Daniela Niepel, Andrew Spencer, L.A.M. Costa, François Goldwasser, H.-S. Radcliffe
Publikováno v:
Annals of Oncology. 27:vi507
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e78a9551b738243d622476d481f3bf75
https://doi.org/10.1093/annonc/mdw390.33
https://doi.org/10.1093/annonc/mdw390.33
Autor:
Qi Jiang, Jianming Wang, Harm Sleeboom, Luis Costa, François Goldwasser, David H. Henry, Vania Hungria, Giorgio V. Scagliotti, Jana Prausova, Susie Jun, Andrew Spencer, Vera Hirsh, Roger Dansey, Saroj Vadhan-Raj, Howard S. Yeh, Wolfgang Willenbacher, Roger von Moos, Penella J. Woll
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(9)
Purpose This study compared denosumab, a fully human monoclonal anti-receptor activator of nuclear factor kappa-B ligand antibody, with zoledronic acid (ZA) for delaying or preventing skeletal-related events (SRE) in patients with advanced cancer and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1061d63ddf30ae3dfa917d3136b2b2f
https://pubmed.ncbi.nlm.nih.gov/21646612
https://pubmed.ncbi.nlm.nih.gov/21646612
Autor:
Anna Pluzanska, Peter J. Wyld, Magdolna Dank, Raquel Lang, Dominique Becquart, Robert S. Smith, Ramon Perez-Carrion, Poonamalle P. Bapsy, Eeva Salminen, Corrado Boni, Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun, H. A. Chaudri-Ross, Fritz Jaenicke, Harm Sleeboom, Justus Apffelstaedt, Alain Monnier, Ajay Bhatnagar, Raymond Snyder
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(11)
Purpose: To analyze overall survival (OS) and update efficacy data for letrozole versus tamoxifen as first-line therapy in postmenopausal women with locally advanced or metastatic breast cancer. Patients and Methods: This multicenter phase III trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34dce635009b5b10ef798601b918e68f
https://pubmed.ncbi.nlm.nih.gov/15284276
https://pubmed.ncbi.nlm.nih.gov/15284276
Autor:
Guy Hechmati, R. von Moos, João Pereira, O. Gunther, N. Maniadakis, Tony Mossman, Jindrich Finek, J.J. Body, E. Terpos, Harm Sleeboom
Publikováno v:
Annals of Oncology. 23:ix447-ix448
Objectives To evaluate European HRU associated with SREs (radiation to bone [RB], surgery to bone [SB], pathologic fracture [PF], spinal cord compression [SCC]). Methods Eligible patients (bone metastases from breast/lung/prostate cancer or multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::799012f174b9bba9f8e22e5b3828a439
https://doi.org/10.1016/s0923-7534(20)33938-7
https://doi.org/10.1016/s0923-7534(20)33938-7